The Impact of Frequent and Unrecognized Hypoglycemia on Mortality in the ACCORD Study

被引:136
作者
Seaquist, Elizabeth R. [1 ]
Miller, Michael E. [2 ]
Bonds, Denise E. [3 ]
Feinglos, Mark [4 ]
Goff, David C., Jr. [5 ]
Peterson, Kevin [6 ]
Senior, Peter [7 ]
机构
[1] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA
[2] Wake Forest Sch Med, Div Publ Hlth Sci, Dept Biostat Sci, Winston Salem, NC USA
[3] NHLBI, Bethesda, MD 20892 USA
[4] Duke Univ, Med Ctr, Div Endocrinol Metab & Nutr, Durham, NC USA
[5] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC 27103 USA
[6] Univ Minnesota, Dept Family Med, Minneapolis, MN 55455 USA
[7] Univ Alberta, Dept Med, Sch Med, Div Endocrinol, Edmonton, AB, Canada
基金
美国国家卫生研究院;
关键词
D O I
10.2337/dc11-0996
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE-The aim of this study was to examine the relationship between frequent and unrecognized hypoglycemia and mortality in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study cohort. RESEARCH DESIGN AND METHODS-A total of 10,096 ACCORD study participants with follow-up for both hypoglycemia and mortality were included. Hazard ratios (95% CIs) relating the risk of death to the updated annualized number of hypoglycemic episodes and the updated annualized number of intervals with unrecognized hypoglycemia were obtained using Cox proportional hazards regression models, allowing for these hypoglycemia variables as time-dependent covariates and controlling for the baseline covariates. RESULTS-Participants in the intensive group reported a mean of 1.06 hypoglycemic episodes (self-monitored blood glucose <70 mg/dL or <3.9 mmol/L) in the 7 days preceding their regular 4-month visit, whereas participants in the standard group reported an average of 0.29 episodes. Unrecognized hypoglycemia was reported, on average, at 5.8% of the intensive group 4-month visits and 2.6% of the standard group visits. Hazard ratios for mortality in models including frequency of hypoglycemic episodes were 0.93 (95% CI 0.9-0.97; P < 0.001) for participants in the intensive group and 0.98 (0.91-1.06; P = 0.615) for participants in the standard group. The hazard ratios for mortality in models, including unrecognized hypoglycemia, were not statistically significant for either group. CONCLUSIONS-Recognized and unrecognized hypoglycemia was more common in the intensive group than in the standard group. In the intensive group of the ACCORD study, a small but statistically significant inverse relationship of uncertain clinical importance was identified between the number of hypoglycemic episodes and the risk of death among participants.
引用
收藏
页码:409 / 414
页数:6
相关论文
共 10 条
[1]   Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial [J].
Bonds, Denise E. ;
Kurashige, Ella Mae ;
Bergenstal, Richard ;
Brillon, David ;
Domanski, Michael ;
Felicetta, James V. ;
Fonseca, Vivian A. ;
Hall, Kathleen ;
Hramiak, Irene ;
Miller, Michael E. ;
Osei, Kwame ;
Simons-Morton, Denise G. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (12A) :80I-89I
[2]   The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study [J].
Bonds, Denise E. ;
Miller, Michael E. ;
Bergenstal, Richard M. ;
Buse, John B. ;
Byington, Robert P. ;
Cutler, Jeff A. ;
Dudl, R. James ;
Ismail-Beigi, Faramarz ;
Kimel, Angela R. ;
Hoogwerf, Byron ;
Horowitz, Karen R. ;
Savage, Peter J. ;
Seaquist, Elizabeth R. ;
Simmons, Debra L. ;
Sivitz, William I. ;
Speril-Hillen, Joann M. ;
Sweeney, Mary Ellen .
BMJ-BRITISH MEDICAL JOURNAL, 2010, 340 :137
[3]   HYPOGLYCEMIA - THE LIMITING FACTOR IN THE MANAGEMENT OF IDDM [J].
CRYER, PE .
DIABETES, 1994, 43 (11) :1378-1389
[4]   Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes [J].
Fanelli, CG ;
Paramore, DS ;
Hershey, T ;
Terkamp, C ;
Ovalle, F ;
Craft, S ;
Cryer, PE .
DIABETES, 1998, 47 (12) :1920-1927
[5]  
Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743
[6]  
*INT ORG STAND, 2003, 15197 ISO WHO
[7]   Resistance to neuroglycopenia: An adaptative response during intensive insulin treatment of diabetes [J].
Jones, TW ;
Borg, WP ;
Borg, MA ;
Boulware, SD ;
McCarthy, G ;
Silver, D ;
Tamborlane, WV ;
Sherwin, RS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (06) :1713-1718
[8]   Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial [J].
Riddle, Matthew C. ;
Ambrosius, Walter T. ;
Brillon, David J. ;
Buse, John B. ;
Byington, Robert P. ;
Cohen, Robert M. ;
Goff, David C., Jr. ;
Malozowski, Saul ;
Margolis, Karen L. ;
Probstfield, Jeffrey L. ;
Schnall, Adrian ;
Seaquist, Elizabeth R. .
DIABETES CARE, 2010, 33 (05) :983-990
[9]   Cognitive Impairment: An Independent Predictor of Excess Mortality A Cohort Study [J].
Sachs, Greg A. ;
Carter, Ravan ;
Holtz, Laura R. ;
Smith, Faye ;
Stump, Timothy E. ;
Tu, Wanzhu ;
Callahan, Christopher M. .
ANNALS OF INTERNAL MEDICINE, 2011, 155 (05) :300-U55
[10]   Severe Hypoglycemia and Risks of Vascular Events and Death. [J].
Zoungas, Sophia ;
Patel, Anushka ;
Chalmers, John ;
de Galan, Bastiaan E. ;
Li, Qiang ;
Billot, Laurent ;
Woodward, Mark ;
Ninomiya, Toshiharu ;
Neal, Bruce ;
MacMahon, Stephen ;
Grobbee, Diederick E. ;
Kengne, Andre Pascal ;
Marre, Michel ;
Heller, Simon .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (15) :1410-1418